Sironax Grants Novartis Exclusive Option to Acquire its Brain Delivery Platform While Retaining Rights to Advance Selected Therapeutic Assets
Published on 08/07/2025 at 18:05 | prnewswire.co.uk
en | CH0012005267 | SIRONAX | boerse | 67970461 |
